Literature DB >> 8611763

BbrPI, an extracellular proteinase inhibitor of Bacillus brevis, protects cells from the attack of exogenous proteinase.

Y Shiga1, H Yamagata, N Tsukagoshi, S Udaka.   

Abstract

BbrPI, an extracellular serine proteinase inhibitors of B. brevis HPD31, is activated by proteolytic processing of an inactive precursor. To discover the physiological role of BbrPI, its deficient mutants were genetically constructed. Although the BbrPI deficient mutant had a higher extracellular proteinase activity than the parent strain, it grew normally. The BbrPI deficient mutant showed higher sensitivity to added trypsin than that of the parent. These observations suggest that the BbrPI may play a role in cellular protection from the attack of exogenous proteinases.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8611763     DOI: 10.1271/bbb.59.2348

Source DB:  PubMed          Journal:  Biosci Biotechnol Biochem        ISSN: 0916-8451            Impact factor:   2.043


  6 in total

1.  Characterization of the serpin-encoding gene of Bifidobacterium breve 210B.

Authors:  Francesca Turroni; Elena Foroni; Mary O'Connell Motherway; Francesca Bottacini; Vanessa Giubellini; Aldert Zomer; Alberto Ferrarini; Massimo Delledonne; Ziding Zhang; Douwe van Sinderen; Marco Ventura
Journal:  Appl Environ Microbiol       Date:  2010-03-26       Impact factor: 4.792

2.  A culture-based method for determining the production of secreted protease inhibitors.

Authors:  David Quintero; David Bermudes
Journal:  J Microbiol Methods       Date:  2014-03-12       Impact factor: 2.363

Review 3.  Prokaryote-derived protein inhibitors of peptidases: A sketchy occurrence and mostly unknown function.

Authors:  Tomasz Kantyka; Neil D Rawlings; Jan Potempa
Journal:  Biochimie       Date:  2010-06-14       Impact factor: 4.079

4.  The periplasmic serine protease inhibitor ecotin protects bacteria against neutrophil elastase.

Authors:  Christopher T Eggers; Iain A Murray; Valerie A Delmar; Anthony G Day; Charles S Craik
Journal:  Biochem J       Date:  2004-04-01       Impact factor: 3.857

5.  Siropins, novel serine protease inhibitors from gut microbiota acting on human proteases involved in inflammatory bowel diseases.

Authors:  Héla Mkaouar; Nizar Akermi; Vincent Mariaule; Samira Boudebbouze; Nadia Gaci; Florette Szukala; Nicolas Pons; Josan Marquez; Ali Gargouri; Emmanuelle Maguin; Moez Rhimi
Journal:  Microb Cell Fact       Date:  2016-11-29       Impact factor: 5.328

6.  Omp19 Enables Brucella abortus to Evade the Antimicrobial Activity From Host's Proteolytic Defense System.

Authors:  Karina A Pasquevich; Marianela V Carabajal; Francisco F Guaimas; Laura Bruno; Mara S Roset; Lorena M Coria; Diego A Rey Serrantes; Diego J Comerci; Juliana Cassataro
Journal:  Front Immunol       Date:  2019-06-26       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.